Related Experiment Video
Updated: Aug 5, 2026
Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
CTLA-4 Promoter Methylation Profile in CD8+ T Cells of Renal Transplant Recipients: A Pilot Study
Mustafa Soyöz1, Tülay Kılıçaslan Ayna, Erhan Tatar
1>From the Faculty of Medicine, Department of Medical Biology, and the Cell, Tissue and Organ Transplantation Research Center, Izmir Katip Celebi University,İzmir Türkiye.
Objectives:
Regulation of immune responses in renal transplant recipients is complex, and the CTLA -4 gene plays a crucial role in maintaining immune tolerance. Methylation of CpG regions in the CTLA -4 promoter may affect its expression, potentially influencing transplant outcomes. This pilot study investigated the relationship between CTLA -4 promoter methylation and gene expression in CD8 + T cells of renal transplant recipients.
Materials And Methods:
We analyzed the CTLA -4 promoter methylation profile in CD8 + T cells from 29 renal transplant recipients using bisulfite sequencing. The methylation status of specific CpG regions was correlated with CTLA -4 expression levels to assess any potential influence of methylation on gene regulation.
Results:
Two patients with hemi -methylated CpG regions in the CTLA -4 promoter showed an increase in CTLA -4 expression. However, no overall correlation between methylation levels and gene expression was observed across the patient cohort.
Conclusions:
The findings suggested that immune responses and treatment outcomes may differ considerably between individuals. In addition, other epigenetic mechanisms may play a role in modulating CTLA -4 expression. These results highlight the complexity of immune regulation in renal transplant recipients and the need for further investigation into the epigenetic factors influencing transplant outcomes.
